Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950138-17-000770
Filing Date
2017-11-30
Accepted
2017-11-30 09:08:18
Documents
1
Period of Report
2017-11-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3063
  Complete submission text file 0000950138-17-000770.txt   4444
Mailing Address C/O GAP, INC. 2 FOLSOM ST. SAN FRANCISCO CA 94105
Business Address
YOUNGBLOOD DR KNEELAND (Reporting) CIK: 0001137820 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 171230019

Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1229
SIC: 2834 Pharmaceutical Preparations